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Abstract
Background: Dengue infection has been an important and serious public health concern in Malaysia ever since its
first reported case here in 1902. Nevertheless, to our knowledge, no nationwide investigation has been carried out
to determine the actual magnitude of dengue endemicity in the Malaysian population. In this study, we describe a
cross sectional seroepidemiology study of dengue IgG seroprevalence in the Malaysian adult population.
Findings: From 1000 subjects (35-74 years old), 91.6% subjects were found to be dengue seropositive. Age is
found to be a significant risk factor associated with dengue seroposivity, where the seroprevalence increased with
every 10 year increase in age. Nevertheless, gender and ethnicity did not have an effect. Interestingly, there were
similar seroprevalence rates between urban and rural samples, showing that dengue is presently not confined to
urban areas in Malaysia.
Conclusions: High dengue IgG seropositivity found in the population is an indication that dengue might be
endemic in Malaysia for a long time into the future. Public awareness, proper vector control and vigilant
surveillance are critical to keep the infection rates low and to prevent outbreaks.
Findings
Background
Dengue infection has been an important public health
concern in Malaysia ever since its first reported case
here in 1902 [1]. The virus (DENV) is transmitted by
the mosquito Aedes aegypti, which is usually found in
urban areas [2]. Across the world, about 100 million
cases of dengue infection and 500 000 cases of dengue
haemorrhagic fever (DHF) with 12 000 deaths were
reported per year [3].
Clinical manifestations of dengue infection ranges
from non-specific febrile illness to classical dengue fever
(DF), DHF and dengue shock syndrome (DSS) [4].
Reported cases that are accounted for by public health
statistics are usually secondary infections, where symp-
toms of DF, DHF or DSS might be present. These clini-
cal manifestations are all thought to be a consequence
of a heightened immune response due to cross-reactive
T-cell responses and/or enhancing dengue antibody
[5-7]. On the other hand, first infection by DENV is
usually subclinical and can present atypically as an
undifferentiated febrile illness [8].
Malaysia, with a population of approximately 27.7 mil-
lion and a population density of 84 per sq. km, has con-
tinuously recorded rising annual cases of dengue
infection since 1980. Major, national dengue outbreaks
were reported in 1974, 1978, 1982 and 1990, exhibiting
a 4-year cycle [9]. According to the 2008 Health Facts
by Malaysian Ministry of Health, the incidence rate of
dengue was 167.76 per 100 000 population with a mor-
tality rate of 0.02 [10]. In the process of becoming a
developed nation, massive infrastructure development in
this country has contributed towards a high incidence of
dengue infection, as urbanization is a favourable factor
for Ae. aegypti breeding and subsequently facilitates the
spread of DENV [11-13].
As primary exposure to the virus is usually asympto-
matic, the actual magnitude of dengue infection in
Malaysia may be larger than expected. We hereby con-
ducted a cross-sectional seroepidemiology study to
determine the prevalence of dengue antibodies in the
Malaysian adult population. This study will be an initial
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step in estimating the extent of the dengue epidemic in
Malaysia.
Study population
The Malaysian Cohort (TMC) is a national project man-
aged by our research institute (UKM Medical Molecular
Biology Institute, UMBI). Initiated in 2006, this nation-
wide cohort recruits Malaysians aged 35 and above; its
participants are considered as the best representative of
the Malaysian adult population as they represent sub-
jects from various ethnic groups, geographical locations
and lifestyles. Detailed information about each partici-
pant is collected along with blood, serum, plasma, lym-
phocytes and urine samples. All subjects were healthy
during the time of sample collection and consented
towards the storage and usage of their samples for med-
ical and epidemiological research. Ethical approval for
The Malaysian Cohort has been granted by the Univer-
siti Kebangsaan Malaysia Research Ethics committee.
There were a total of 13725 participants recruited into
the TMC from 1 January 2008 until 31 December 2008.
We randomly selected 1000 subjects from the initial
population of 13725 using Minitab 15 software (Minitab
Inc., Pennsylvania, USA), and retrieved their serum sam-
ples for our study. Socio-demographic data of the sub-
jects such as gender, age, ethnicity, locality (urban/rural)
were also retrieved from the TMC database (Table 1).
Dengue IgG antibody detection
Serum samples were measured for the presence of den-
gue virus-specific IgG antibodies using the PanBio Den-
gue IgG INDIRECT enzyme-linked immunosorbent
assay (ELISA) (Inverness Medical Innovations Australia
Pty Ltd, Queensland, Australia). This kit identifies anti-
bodies to all four DENV serotypes but cannot differenti-
ate between each serotype. Positive result of dengue IgG
antibody indicates previous exposure to DENV. Inter-
pretation of ELISA results were made according to
instructions from the manufacturer.
Data Analysis
Data analysis was performed using Statistical Package
for Social Science (SPSS) 16.0 (SPSS Inc., Chicago,
USA). Chi square analysis was used to determine the
relationship between genders, age groups, ethnicity and
locality with dengue IgG seroprevalence. Logistic regres-
sion analysis was used to determine risk factors asso-
ciated with positive dengue IgG. Odd ratios and their
95% confidence intervals were provided as estimates of
the effect size and the chi-square tests were conducted
at 3% level of significance while logistic regression tests
were conducted at 5% level of significance.
Result and Discussion
From the 1000 subjects surveyed, 916 (91.60%) were
positive for dengue IgG, where 541 (90.17%) females
and 375 (93.75%) males were dengue seropositive. This
shows that a large proportion of the Malaysian adult
population has been exposed to DENV. Ethnically, den-
gue IgG seroprevalence were as follows: Malay, 91.75%
(523/570); Chinese, 91.37% (339/371); Indian and others,
91.53% (54/59) (Note: In 2008, the ethnicity ratio of
recruited subjects in the TMC was comparable to the
national ratio of Malay: Chinese: Indian = 6:3:1). Chi
square analysis showed no significant difference in
Table 1 Sociodemographic data of 1000 subjects whose serum samples were used in this study
Sociodemographic factor Number of subjects* Dengue IgG positive¥ Dengue Seroprevalence£
Gender
Male 400 (40.0%) 375 93.75
Female 600 (60.0%) 541 90.17
Age Range
35-44 137 (13.7%) 110 80.29
45-54 474 (47.4%) 439 92.62
55-64 338 (33.8%) 319 94.38
65-74 51 (5.1%) 48 94.12
Median Age, y (Range) 53 (35-74)
Ethnicity
Malay 570 (57.0%) 523 91.75
Chinese 371 (37.1%) 339 91.37
Indian & Others 59 (5.9%) 54 91.53
Locality
Rural 398 (39.8%) 362 90.95
Urban 602 (60.2%) 554 92.03
*Except where indicated, values are (n, %)
¥ Except where indicated, values are (n)
£ Except where indicated, values are (%)
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dengue IgG seroprevalence between different ethnic
groups (c2 = 0.43, p = 0.979) and gender (c2 = 4.055, p
= 0.045); the seroprevalence rates were more than 90%
for each category for both demographic factors (gender
and ethnicity). This shows that a large proportion of the
Malaysian adult population has been exposed to DENV;
there were neither gender bias nor ethnicity preferences.
Nevertheless, we noticed that dengue IgG seropreva-
lence rates increased with age among our subjects, and
the difference between age groups was significant (p <
0.001) (Table 1). The odds of dengue seropositivity
(compared to the 35-44 years old age group) were as
follows: 45-54 years old, 3.08 (95% CI: 1.79-5.31); 55-64
years old, 3.89 (95% CI: 2.07-7.30) (p < 0.001); and 65-
74 years old, 3.59 (95% CI: 1.03-12.46) (p = 0.045)
(Table 2). This finding is in conjunction with reports
that dengue seroprevalence will increase for every 10
year increment in age; older subjects will have a higher
chance of infection [4,14]. As the TMC only recruits
adults 35 years old and above, dengue seroprevalence in
the younger population is not known; it remains to be
investigated if there was a sharp rise in the seroconver-
sion rate during childhood/young adulthood, or whether
the conversion has occurred gradually.
Surprisingly, there was no difference (p = 0.550) in
the dengue IgG seroprevalence between subjects stay-
ing in urban areas (92.03%, 554/602) compared to
those living in rural communities (90.95%, 362/398),
even though dengue is usually described as an “urban”
disease [15]. In our study, samples from “urban” areas
were retrieved from the TMC control centre (based in
our university hospital, UKM Medical Centre in Kuala
Lumpur, Malaysia) and also town areas; while samples
categorized as “rural” were collected from subjects liv-
ing in villages and also settlers in palm oil plantations
from the Federal Land Development Authority
(FELDA) communities nationwide. Hayes et al. (1990)
reported that dengue antibody seroprevalence was high
in urban (66%) compare to rural populations (26%) or
jungle areas (32-64%) [16]. Population-based study in
rural Amazonia of Brazil also showed a lower baseline
DENV seropositivity rate of 18.3% [17]. Nevertheless,
our study showed that there was no difference in the
seroprevalence between urban and rural areas. This
phenomenon might be caused by rising vector popula-
tions in rural areas. A study by Chen et al. in 2005
gave an ovitrap index of 56% in a rural settlement
[18]. However, in a separate study carried out 2 years
later in two insular rural settlements, the ovitrap index
was 63% and 80%, respectively [19]. In addition to ris-
ing vector populations, improved modes of transporta-
tion which allow migration of viramic subjects from
one place to another might have facilitated the spread
of dengue from urban into rural areas.
The high dengue IgG seropositivity found in the
Malaysian adult population (91.6%) indicates that 9 out
of 10 adults are already exposed to dengue infection.
This percentage of dengue IgG prevalence is higher
compared to that among adults in Singapore (45%) and
Central Brazil (29.5%) based on house-hold surveys, but
lower compared to the study among adults in Santo
Domingo, Dominican Republic (98%) [4,11,14]. The
major drivers for high dengue IgG seroprevalence in
Malaysia are probably demographic changes, massive
urbanization in town areas, high density of vector popu-
lations such as Ae. aegypti in both urban and rural areas
and changes in the usage of agricultural land in rural
locations which promotes the propagation of Aedes sp
[11,18]. Lack of effective mosquito control programs
may have also helped to spread the virus.
In this study, the IgG detected was considered to be
specific for DENV, even though the ELISA kit used
might also detect other flavivirus antibodies such as JE
and Yellow Fever (YF). In Malaysia, DENV and JE
viruses are two of the more common endemic flavi-
viruses; YF and West Nile viruses have never been iso-
lated here. Compared to dengue, the number of JE cases
in Malaysia is minimal (annual incidence of JE virus
infection is 9.8 per 100 000 population compared to
167.76 per 100 000 population for dengue [10,20].
Other flaviviruses found in Malaysia such as Tembusu
and Langat do not cross-react with dengue antibodies
[21]. Taking it all together, our positive ELISA results
were more likely to be caused by dengue IgG than anti-
bodies from other flaviviruses.
Conclusion
To the best of our knowledge, this is the first dengue
IgG seroprevalence study carried out on healthy adults
in Malaysia. High dengue IgG seropositivity (91.60%)
found in the population is an indication that dengue
might be endemic in Malaysia for a long time into the
future. Public awareness, proper vector control and vigi-
lant surveillance are critical to keep the infection rates
down and to prevent outbreaks. It remains to be deter-
mined which dengue serotype is more dominant, and if
the dengue serotypes found in this population are
Table 2 Univariate analysis of risk factor for dengue IgG
seropositivity
Covariates Odd Ratio (OR) 95% Confidence Interval (CI) P-value§
Age Range
35-44 1.00 (1.79, 5.31) < 0.001
45-54 3.08 (2.07, 7.30) < 0.001
55-64 3.89 (1.03, 12.46) 0.045
65-74 3.59
Bold§ indicates significant values, where p < 0.05
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similar to or different from the current circulating sero-
types in the vectors.
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